- Research works
- 1 fractional, all time
- Citations
- 22 18.2 per fractional work
- Top-10% rate
- 28.6% record average 16.5%
- Open access
- 17% world 28%
Not ranked overall: Stichting HemoBase is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which research topics does Stichting HemoBase publish most on?
By volume in 2022–2025: Cancer-related molecular mechanisms research, Chronic Myeloid Leukemia Treatments, Lymphoma Diagnosis and Treatment and Ferroptosis and cancer prognosis.
- 1 Cancer-related molecular mechanisms research Cancer Research 0 works
- 2 Chronic Myeloid Leukemia Treatments Hematology 0 works
- 3 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 0 works
- 4 Ferroptosis and cancer prognosis Pulmonary and Respiratory Medicine 0 works
- 5 Advanced Proteomics Techniques and Applications Spectroscopy 0 works
- 6 Cancer Genomics and Diagnostics Cancer Research 0 works
- 7 RNA and protein synthesis mechanisms Molecular Biology 0 works
- 8 RNA modifications and cancer Molecular Biology 0 works
- 9 Acute Lymphoblastic Leukemia research Public Health, Environmental and Occupational Health 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Stichting HemoBase's research output changed?
Other research institutions in Leeuwarden
- Medisch Centrum Leeuwarden
- Fryske Akademy
- Stenden University of Applied Sciences
- Van Hall Larenstein University of Applied Sciences
- GGZ Friesland
- NHL University of Applied Sciences
- Radiotherapeutisch Instituut Friesland
- Friesland College
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.